Search hospitals > California > Long Beach
Ark Clinical Research
Claim this profileLong Beach, California 90806
Global Leader in Coronavirus
Conducts research for Type 2 Diabetes
Conducts research for Flu
Conducts research for COVID-19
Conducts research for Obesity
38 reported clinical trials
4 medical researchers
Summary
Ark Clinical Research is a medical facility located in Long Beach, California. This center is recognized for care of Coronavirus, Type 2 Diabetes, Flu, COVID-19, Obesity and other specialties. Ark Clinical Research is involved with conducting 38 clinical trials across 57 conditions. There are 4 research doctors associated with this hospital, such as Apinya Bee Vutikullird, Kenneth T Kim, Apinya Vutikullird, DO, and Justin Yanuck, MD.Top PIs
Apinya Bee VutikullirdArk Clinical Research5 years of reported clinical research
Studies Coronavirus
Studies Cardiovascular Disease
5 reported clinical trials
9 drugs studied
Kenneth T KimGSK Investigational Site4 years of reported clinical research
Studies Asthma
Studies Coronavirus
5 reported clinical trials
13 drugs studied
Apinya Vutikullird, DOArk Clinical Research2 years of reported clinical research
Studies Prevention of Norovirus Infection
Studies Norovirus
2 reported clinical trials
2 drugs studied
Justin Yanuck, MD307 - Ark Clinical Research2 years of reported clinical research
Studies Coronavirus
1 reported clinical trial
2 drugs studied
Clinical Trials running at Ark Clinical Research
Cardiovascular Disease
Type 2 Diabetes
Stroke
Liver Fibrosis
Fatty Liver Disease
Chronic Urticaria
Asthma
Elevated Lipoprotein
Chronic Kidney Disease
Heart Disease
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting1 award Phase 3
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
Vicadrostat + Empagliflozin
for Type 2 Diabetes and Hypertension
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin. Participants are put into 2 groups randomly, which means by chance. One group takes vicadrostat and empagliflozin tablets, and the other group takes placebo tablets with empagliflozin. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take a tablet once per day for 2 and a half years and up to 4 years and 3 months. All participants also continue their medication for type 2 diabetes, high blood pressure, and cardiovascular disease. Participants have an equal chance of receiving the study medicine or placebo. Participants are in the study for up to 4 years and 3 months. During this time, they visit the study site regularly. During these visits, doctors collect information about participants' health and take blood samples. The doctors document when participants experience cardiovascular events. The doctors also regularly check participants' health and take note of any unwanted effects.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ark Clinical Research?
Ark Clinical Research is a medical facility located in Long Beach, California. This center is recognized for care of Coronavirus, Type 2 Diabetes, Flu, COVID-19, Obesity and other specialties. Ark Clinical Research is involved with conducting 38 clinical trials across 57 conditions. There are 4 research doctors associated with this hospital, such as Apinya Bee Vutikullird, Kenneth T Kim, Apinya Vutikullird, DO, and Justin Yanuck, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.